Fundraising FoxElaia — 2024 Investments
11 investments dated 2024 · listed companies and verified rows first · show all
HEPHAISTOS is a biopharmaceutical company developing third-generation innate immune boosters (TLR4 agonists) that convert myeloid-rich, immunotherapy-resistant tumors into immunotherapy-responsive tumors.
BiotechMedical DevicesOrsay, FR
Martine Caroff(Scientific Founder)inFrederic Caroff(CEO)inFrederique Brune(CDO)inStephan Braun(CMO)inJerome Kerzerho(CSO)inChristel Lonneux(CFO and HR)in
Co-investorsxista science venturesAngels SantéFemmes Business Angels
Aqemia applies atomic-scale physics and generative AI to accelerate drug discovery and molecular design, enabling faster identification of innovative medicines for unmet therapeutic needs.
AI & Machine LearningBiotechDeep Tech
Maximilien Levesque(Founder)inEmmanuelle Martiano-Rolland(COO and Co-Founder)inEmmanuelle Martiano(Founder)Emmanuelle Martiano Rolland(Founder)Maximilien Levesque Emmanuelle Martiano(Founder)
Co-investorsCathay InnovationPSL Innovation FundBpifranceEurazeo
SaaS 'Stratech' platform using AI to automate market analysis and strategic scenario planning for decision-making.
Co-investorsPolytechnique Ventures
dottxt builds tools to make large language models composable and reliable by enforcing schemas and contracts, enabling AI systems to behave predictably like traditional software.
AI & Machine LearningData & InfrastructureDeveloper ToolsEnterprise SoftwareJersey City, US
Rémi Louf(Founder)inBrandon T. Willard(Director)inJulien Chaumond(Cofounder & CTO)Daniel Gerlanc(Executive Officer, Director)Brandon Willard(Founder)Dan Gerlanc(Founder)
Co-investorsKima VenturesScript CapitalSTATION FCommon MagicEQT Ventures
Dunia operates an autonomous laboratory platform that combines physics-informed AI, robotic automation, and a large-scale experimental data engine in a closed-loop Design-Make-Test-Analyze cycle to discover and optimize materials such as electrochemical catalysts.
AI & Machine LearningDeep TechNew Materials
Marcus Tze-Kiat Ng(Founder)in
Co-investorsDeep Science VenturesKindred CapitalPace VenturesThird DerivativeEICredalpine
Mitiga Solutions provides physical climate risk analytics that assess exposure across large portfolios of assets, regions, and business units, identifying where risk concentrates and how it evolves under future scenarios.
AI & Machine LearningClimate TechFintechInsurTechSaaSBarcelona, ES
Alejandro Marti(Founder)inMauricio Hanzich(Co-founder)in
Co-investorsCREAS IMPACTO GLOBAL SGEICFaberKibo VenturesShip2B
NanoCorp builds autonomous AI agents that create and operate full companies from a single natural language prompt, handling product development, website deployment, customer acquisition, payments, and operations without requiring code or a team.
AI & Machine LearningConsumerCreator EconomySaaSSan Francisco, US
Pierre-Louis Biojout(CTO)inPaul-Louis Venard(CEO)
Co-investorsY CombinatorPioneerTranspose Platform ManagementAndreessen HorowitzInovia Capital
Nijta develops automated anonymisation technology that removes personal information from data—including voice and customer conversations—so businesses can use and share it while complying with privacy regulations like GDPR.
AI & Machine LearningCybersecurityData & Infrastructure
phospho builds AI models to control real-world robots and provides an open-source, developer-focused robotics toolkit.
AI & Machine LearningDeveloper ToolsRobotics
Co-investorsKima VenturesY Combinator
Pixacare provides AI-powered wound documentation and tracking software that captures medical photography, performs automated wound measurements, and enables remote monitoring of healing for hospitals and clinics.
AI & Machine LearningHealthtechMedical DevicesStrasbourg, FR
Vincent Marceddu(Founder)in
Co-investors50 Partners
Qantev builds AI software that helps large insurers manage and optimize their health and life claims operations.
AI & Machine LearningDigital HealthInsurTechParis, FR
Tarik Dadi(CEO)inHadrien De March(CTO)in
Co-investorsBlossom CapitalOmnes CapitalEntrepreneur FirstPSL Innovation FundSTATION FRAISE
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.